AOBiome Therapeutics, Inc. is a life sciences company focused on transforming human health by developing microbiome-based therapies for inflammatory conditions.
Cambridge, MA
Joined April 2013
- Tweets725
- Following164
- Followers1.3K
- Likes367
Latest News from AOBiome's cosmetic division:
We've heard your requests for stronger Mists. PRO & MAX Mists are our trusted live probiotic formula with higher concentrations of our revolutionary ingredient: ammonia-oxidizing bacteria.
Get free shipping on all PRO & MAX Mist orders!
aobiomecosmetics.com/?utm_so…
AOB Pharma receives European Medicines Agency positive decision on the pediatric investigation plan, supporting future development of B244 for the treatment of mild to moderate atopic dermatitis in children, adolescents, and adults in the European Union
biospace.com/press-releases/…
Veristat and AOBiome Therapeutics to Present at Clinical Outsourcing Group on Essential Elements of Effective Partnerships with CROs
biospace.com/press-releases/…
AOB Pharma reveals new insights via metabolomic analysis of B244, supporting clinical readouts & suggesting investigation of potential new avenues for treatment
health.einnews.com/pr_news/8…
AO+ Mist is Available Again!
The D23 AO+ Mist Topical Probiotic Spray is the same product that has been previously sold as AO+ MIST & Mother Dirt AO+ Restorative Mist.
@aobiome @probiotics @MotherDirt
aobiomecosmetics.com/product…
AOBiome announces the publication of positive Phase 2b results in The Lancet’s eClinicalMedicine for B244 in the treatment of mild-to-moderate atopic dermatitis and moderate-to-severe pruritus.
aobiome.com/pressreleases/ao…
AOBiome Therapeutics, Inc retweeted
Todd Krueger, the President & CEO of @aobiome featured in our latest edition, "Top 10 Global Business Leaders Making a Difference in 2022"
#biotechnology #research #biotherapeutic #aobiome
bit.ly/3OrW2xX
This November AOBiome's CEO Todd Krueger will be speaking at Microbiome Connect: USA, sharing expertise and insights with the microbiome community.
Join him & 300+ leaders in the space for 3 exciting days of learning.
Download the agenda hubs.ly/Q01nTy-r0
See you there!
AOBiome Therapeutics, Inc retweeted
Listed by #The_Silicon_Review under 50 Innovative companies to watch 2022 @aobiome Therapeutics is a leading clinical stage biotherapeutic company focusing
thesiliconreview.com/magazin…
#aobiome #biotherapeutic #research #clinic #leadingclinicalstage #drugdevelopment #inflammatory
AOBiome’s B244 demonstrated positive results from its Phase 2b trial for both Pruritus (Itch) and Appearance of Atopic Dermatitis (Eczema)
#clinicaltrials #eczema #biotherapeutics #atopicdermatitis #pruritus
aobiome.com/pressreleases/ao…
AOBiome Therapeutics, Inc retweeted
AOBiome 547 subject Phase 2b trial for treatment of Pruritus (Itch) associated w/ Atopic Dermatitis (Eczema) achieves landmark recruitment goal in largest clinical trial ever powered by a live topical Biotherapeutic. prn.to/3CeRq6E
AOBiome's CEO Todd Krueger is speaking at @LongwoodFund Healthcare Leaders webcon Oct 4-5 with biopharma CEOs, Head of FDA, Gov Baker, top academics. Join the meeting here: longwoodhealthcareleaders.co… #longwoodhealthcareleaders
AOBiome's CEO Todd Krueger will be discussing "Ammonia Oxidizing Bacteria as a live topical therapeutic" hubs.ly/H0W7PH20
New 30 Patient Study Of AOBiome's New Shelf-Stable Formulation Of Its Ammonia Oxidizing Bacteria (AOB) Shows Reduction Of Itch Levels In Both Pediatric And Adult Subjects Who Suffer From Eczema.
prnewswire.com/news-releases…
Do you suffer from itch caused by eczema? Consider joining a clinical research study! Atopic dermatitis or more commonly known as eczema is a condition that makes your skin red and itchy. #Eczema #clinicaltrial
aobiome.com/aobiome-pruritus…
AOBiome's CEO Todd Krueger is Speaking at the COVID-19 R2R Conference.
Honored to speak alongside some greats at @Everbridge #COVIDR2R including the 42nd President, @BillClinton, @SteveForbesCEO, and @Madeleine as well as world leaders, Reserve Now: bit.ly/33eUUa9
